209 related articles for article (PubMed ID: 26385505)
61. Prognostic role of brachial reactivity in patients with ST myocardial infarction after percutaneous coronary intervention.
Wang X; Guo F; Li G; Cao Y; Fu H
Coron Artery Dis; 2009 Nov; 20(7):467-72. PubMed ID: 19641459
[TBL] [Abstract][Full Text] [Related]
62. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
[TBL] [Abstract][Full Text] [Related]
63. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
[TBL] [Abstract][Full Text] [Related]
64. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.
Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL
Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357
[TBL] [Abstract][Full Text] [Related]
65. Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock.
Yang JH; Song PS; Song YB; Hahn JY; Choi SH; Choi JH; Lee SH; Jeong MH; Kim YJ; Gwon HC
Crit Care; 2013 Oct; 17(5):R218. PubMed ID: 24090250
[TBL] [Abstract][Full Text] [Related]
66. Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
Fukutomi M; Toriumi S; Ogoyama Y; Oba Y; Takahashi M; Funayama H; Kario K
Catheter Cardiovasc Interv; 2019 Apr; 93(5):E262-E268. PubMed ID: 30244539
[TBL] [Abstract][Full Text] [Related]
67. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389
[TBL] [Abstract][Full Text] [Related]
68. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction.
Cakmak M; Cakmak N; Cetemen S; Tanriverdi H; Enc Y; Teskin O; Kilic ID
Can J Cardiol; 2008 May; 24(5):375-8. PubMed ID: 18464942
[TBL] [Abstract][Full Text] [Related]
69. Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention.
Zheng J; Cheng J; Zhang Q; Qi C; Wang T; Xiao X
Medicine (Baltimore); 2016 May; 95(19):e3696. PubMed ID: 27175711
[TBL] [Abstract][Full Text] [Related]
70. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
[TBL] [Abstract][Full Text] [Related]
71. Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.
Eppinga RN; Hartman MH; van Veldhuisen DJ; Lexis CP; Connelly MA; Lipsic E; van der Horst IC; van der Harst P; Dullaart RP
PLoS One; 2016; 11(1):e0145719. PubMed ID: 26808474
[TBL] [Abstract][Full Text] [Related]
72. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
73. Glycated hemoglobin vs fasting plasma glucose as a predictor of left ventricular dysfunction after ST-elevation myocardial infarction.
Tsai JP; Tian J; Wang WY; Ng AC
Can J Cardiol; 2015 Jan; 31(1):44-9. PubMed ID: 25547549
[TBL] [Abstract][Full Text] [Related]
74. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
[TBL] [Abstract][Full Text] [Related]
75. Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Yang L; Dong H; Lu H; Liao Y; Zhang H; Xu L; Tan Y; Cao S; Tan J; Fu S
Medicine (Baltimore); 2019 Mar; 98(12):e14920. PubMed ID: 30896649
[TBL] [Abstract][Full Text] [Related]
76. Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients.
Ghaffari S; Niafar F; Separham A; Niafar M; Pourafkari L; Nader ND
Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):305-13. PubMed ID: 25976908
[TBL] [Abstract][Full Text] [Related]
77. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
78. Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction.
Reinstadler SJ; Klug G; Feistritzer HJ; Kofler M; Pernter B; Göbel G; Henninger B; Müller S; Franz WM; Metzler B
Eur Heart J Cardiovasc Imaging; 2016 Feb; 17(2):169-76. PubMed ID: 26056134
[TBL] [Abstract][Full Text] [Related]
79. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients.
Tenerz A; Nilsson G; Forberg R; Ohrvik J; Malmberg K; Berne C; Leppert J
J Intern Med; 2003 Nov; 254(5):494-503. PubMed ID: 14535972
[TBL] [Abstract][Full Text] [Related]
80. Predictive Value of the Acute-to-Chronic Glycemic Ratio for In-Hospital Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Gao S; Liu Q; Ding X; Chen H; Zhao X; Li H
Angiology; 2020 Jan; 71(1):38-47. PubMed ID: 31554413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
